Proel EpaM G Koronis SA

Proel is a prominent Greek pharmaceutical company specializing in the development, production, and commercialization of high-quality medicinal products. Founded in 1937 and based in Athens, the company maintains a robust portfolio of generic and branded pharmaceuticals across several therapeutic areas, including cardiology, gastroenterology, and the central nervous system. Proel operates its own manufacturing facilities in Peristeri, which are compliant with Good Manufacturing Practice (GMP) standards. The company serves the domestic Greek market and has a long-standing reputation for providing affordable and effective healthcare solutions. As a family-owned enterprise, it remains a key player in the Greek pharmaceutical industry and is an active member of the Panhellenic Association of Pharmaceutical Industries.